Our team | Center for Biomedical System Design

Gigi Hirsch, MD
Director
Center for Biomedical System Design & NEWDIGS;
Assistant Professor, Department of Medicine, TUSM
Gigi.Hirsch@tuftsmedicine.org

Azrina Azhar, MS, MPA,
Project Director, CBSD
NurAzrina.Azhar@tuftsmedicine.org

Jane F. Barlow, MD, MPH, MBA
Senior Advisor, NEWDIGS
Jane.Barlow@tuftsmedicine.org

Karen Geary, MHA
Senior Advisor, NEWDIGS
Paying for Cures Toolkit Team Lead
Karen.Geary@tuftsmedicine.org

John Glasspool
Senior Advisor, NEWDIGS

Sharon Phares, PhD, MPH
Associate Director for Research, CBSD
sharon.phares@tuftsmedicine.org

Katie Phillip, MPH
Research Associate, NEWDIGS
Katie.Phillip@tuftsmedicine.org

Ron Potts, MD
Senior Advisor, NEWDIGS

Eric A. Small
Program Manager, CBSD
Eric.A.Small@tuftsmedicine.org

Mark Trusheim, MSc
Strategic Director, NEWDIGS
Mark.Trusheim@tuftsmedicine.org

Colin Young, PhD
Senior Advisor, NEWDIGS
Colin.Young@tuftsmedicine.org

Charles L. Cooney, PhD
Robert T. Haslam Professor of Chemical Engineering, MIT; Faculty Director, Deshpande Center for Technological Innovation

Nick Crabb, PhD
Program Director, Scientific Affairs National Institute for Health & Clinical Excellence (NICE)

Michael A. Cusumano, PhD
Sloan Management Review Distinguished Professor of Management, MIT Sloan School of Management

Hans-Georg Eichler, MD, MSc
Consulting Physician, Association of Austrian Social Insurance Institutions

Elazer Edelman, MD, PhD, FACC
Thomas D & Virginia W Cabot Professor of HST, Health Sciences and Technology Program, MIT

Andrew Lo, PhD
Charles E. and Susan T. Harris Professor of Finance; Director, Laboratory for Financial Engineering, MIT Sloan School of Management

Kenneth A. Oye, PhD
Professor of Political Science and Engineering Systems; Co-Director, MIT Program on Emerging Technologies, MIT

Alex 'Sandy' Pentland, PhD
Professor of Media Arts and Sciences, Toshiba Professor, MIT Media Lab; Director, MIT Media Lab Entrepreneurship Program

Richard Platt, MD, MSc
Executive Director, Harvard Pilgrim Health Care Institute, Department of Population Medicine, Harvard Medical School

Peter Saltonsall
President and CEO National Organization for Rare Disorders (NORD)

Harry Selker, MD, MSPH
Dean, Clinical and Translational Science Institute Institute for Clinical Research & Health Policy Studies Tufts University

Michael S. Sherman, MD, MBA, MS, CPE
Venture Partner, RA Capital Management LP

Anthony Sinskey, ScD
Faculty Director, CBI; Professor of Biology and Health Sciences and Technology, MIT

Peter Szolovits, PhD
Professor, Department of Electrical Engineering and Computer Science (EECS), Institute for Medical Engineering and Science (IMES), MIT

The role of the Executive Advisory Network is to contribute ideas for projects, vet new opportunities, and disseminate emerging insights and recommendations from NEWDIGS activities. The Executive Advisory Network will assist with outreach to potential sponsors and endorse the goals of NEWDIGS projects as well the alignment of new projects with NEWDIGS mission and priorities; It has no financial or fiduciary responsibility, nor does it make any product-specific decisions. Typical agenda items include research updates, workshop opportunities, new mini-consortia proposals and pending publications.

Nick Crabb, PhD
Program Director, Scientific Affairs National Institute for Health & Clinical Excellence (NICE)

Kenneth A. Oye, PhD
Associate Professor of Political Science and Engineering Systems; Co-Director, MIT Program on Emerging Technologies Massachusetts Institute of Technology

Anne-Virginie Eggimann, MSc
Vice President, Regulatory Science bluebird bio

Peter Saltonsall
President and CEO National Organization for Rare Disorders (NORD)

Hans-Georg Eichler, MD, MSc
Senior Medical Officer European Medicines Agency

Harry Selker, MD, MSPH
Dean, Clinical and Translational Science Institute Institute for Clinical Research & Health Policy Studies Tufts University

Gigi Hirsch, M.D.
Executive Director, Center for Biomedical Innovation, Massachusetts Institute of Technology; Director NEWDIGS

David R. Strutton, PhD
Vice President of Global Pharmaceuticals and Policy Research, Center for Observational and Real-World Evidence, Merck & Co., Inc.

Mark Trusheim, MSc
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting

Jane F. Barlow, MD, MPH, MBA
Senior Advisor, NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project; CEO, Jane Barlow & Associates

Ernest Berndt, PhD, MS
Louis E Seley Professor of Applied Economics, Sloan School of Management; Co-director Biomedical Enterprise Program

Stella Blackburn, MD, MA, MSc
Senior Advisor, Regulatory Science, NEWDIGS; Honorary Associate Professor, London School of Hygiene & Tropical Medicine; Vice President, Global Head of Early Access and Risk Management, IQVIA

Jeff Brown, PhD
Assistant Professor, Department of Population Medicine, Harvard Medical School

Chester Drum, MD, PhD
Assistant Professor, Department of Medicine, National University of Singapore

R. John Glasspool
Senior Advisor, NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project

Judy Maro, PhD, MS
Research Affiliate, Center for Biomedical Innovation, Research Fellow in the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute

Kenneth A. Oye, PhD
Associate Professor of Political Science and Engineering Systems; Co-Director, MIT Program on Emerging Technologies Massachusetts Institute of Technology

Nitin R. Patel, PhD
Research Affiliate, MIT Center for Biomedical Innovation; Founder, Chairman, and Chief Technology Officer, Cytel Statistical Software and Services

Casey Quinn, PhD
Research Advisor, NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project

G.K. Raju, PhD
CBI Distinguished Fellow; Chairman, CBI Biomanufacturing Steering Committee; Executive Director, MIT Pharmaceutical Manufacturing Initiative

Mark Trusheim, MSc
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting